Literature DB >> 23611257

Investigation of the phenotype heterogeneity in severe hemophilia A using thromboelastography, thrombin generation, and thrombodynamics.

Ivan D Tarandovskiy1, Anna N Balandina, Konstantine G Kopylov, Nadezhda I Konyashina, Maria A Kumskova, Mikhail A Panteleev, Fazoil I Ataullakhanov.   

Abstract

BACKGROUND: Hemophilia A (HA) patients with similar factor VIII levels can demonstrate varying bleeding tendencies. In particular, 10-15% of all severe HA patients (FVIII:C<1IUdL(-1)) do not require regular replacement therapy. Modern global coagulation assays can help to detect and study this "mild" bleeding phenotype. Here, we investigated the coagulation status of different bleeding phenotypes using various types of global coagulation assays.
MATERIALS AND METHODS: Ten HA patients with severe phenotype and eleven patients with mild phenotypes were included in the study. For each patient, thromboelastography (TE), thrombodynamics (TD), and kaolin- or tissue factor-induced thrombin generation (TG) were measured. TG in platelet-rich plasma (PRP) was investigated using our original modification when the thrombin generation curve showed two peaks, previously shown to depend on platelet activity. We also utilized TG and TD with the addition of thrombomodulin.
RESULTS: The second peak amplitude and ETP of PRP TG were the only parameters that were significantly higher in mild bleeders (peak 41.6 ± 3.5 nM, ETP 1966 ± 169 nM*min) than in patients with severe bleeding (peak 28.3 ± 3.3 nM, ETP 1359 ± 130 nM*min).
CONCLUSIONS: Our results suggest that severe and mild HA phenotypes could be distiguished by TG assay in PRP suggesting that difference in platelet activity can be involved in the phenotype formation. According to our previous results we can suppose that the mechanism of the phenotypic heterogeneity is linked with TG mediated by PS-expressing platelets.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23611257     DOI: 10.1016/j.thromres.2013.04.004

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  9 in total

1.  Procoagulant impact of the plasmapheresis procedure on coagulation state of collected plasma.

Authors:  Stepan Surov; Ruzanna Ovsepyan; Igor Vysochin; Elena Kobzeva; Valeriy Khvatov; Mikhail Panteleev; Tatiana Vuimo
Journal:  Blood Transfus       Date:  2015-07-09       Impact factor: 3.443

2.  A mathematical model of coagulation under flow identifies factor V as a modifier of thrombin generation in hemophilia A.

Authors:  Kathryn G Link; Michael T Stobb; Matthew G Sorrells; Maria Bortot; Katherine Ruegg; Marilyn J Manco-Johnson; Jorge A Di Paola; Suzanne S Sindi; Aaron L Fogelson; Karin Leiderman; Keith B Neeves
Journal:  J Thromb Haemost       Date:  2019-11-01       Impact factor: 5.824

Review 3.  Viscoelastic testing inside and beyond the operating room.

Authors:  Liang Shen; Sheida Tabaie; Natalia Ivascu
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

4.  Global/integral assays in hemostasis diagnostics: promises, successes, problems and prospects.

Authors:  Mikhail A Panteleev; Hendrik Coenraad Hemker
Journal:  Thromb J       Date:  2015-01-28

5.  New Infestin-4 Mutants with Increased Selectivity against Factor XIIa.

Authors:  Vladimir N Kolyadko; Sofya V Lushchekina; Tatiana A Vuimo; Stepan S Surov; Ruzanna A Ovsepyan; Vera A Korneeva; Ivan I Vorobiev; Nadezhda A Orlova; Leonid Minakhin; Konstantin Kuznedelov; Konstantin V Severinov; Fazoil I Ataullakhanov; Mikhail A Panteleev
Journal:  PLoS One       Date:  2015-12-15       Impact factor: 3.240

Review 6.  Thrombin generation for monitoring hemostatic therapy in hemophilia A: A narrative review.

Authors:  Marieke J A Verhagen; Lars L F G Valke; Saskia E M Schols
Journal:  J Thromb Haemost       Date:  2022-01-28       Impact factor: 16.036

7.  Thromboelastography and thrombin generation assessments for pediatric severe hemophilia A patients are highly variable and not predictive of clinical phenotypes.

Authors:  Natalie Mathews; Fred G Pluthero; Margaret L Rand; Ann Marie Stain; Manuel Carcao; Victor S Blanchette; Walter H A Kahr
Journal:  Res Pract Thromb Haemost       Date:  2022-09-26

8.  SYMPHONY consortium: Orchestrating personalized treatment for patients with bleeding disorders.

Authors:  Marjon H Cnossen; Iris van Moort; Simone H Reitsma; Moniek P M de Maat; Roger E G Schutgens; Rolf T Urbanus; Hester F Lingsma; Ron A A Mathot; Samantha C Gouw; Karina Meijer; Annelien L Bredenoord; Rieke van der Graaf; Karin Fijnvandraat; Alexander B Meijer; Emile van den Akker; Ruben Bierings; Jeroen C J Eikenboom; Maartje van den Biggelaar; Masja de Haas; Jan Voorberg; Frank W G Leebeek
Journal:  J Thromb Haemost       Date:  2022-06-02       Impact factor: 16.036

9.  Pharmacodynamic monitoring of factor VIII replacement therapy in hemophilia A: Combining thrombin and plasmin generation.

Authors:  Lars L F G Valke; Laura H Bukkems; Wideke Barteling; Britta A P Laros-van Gorkom; Nicole M A Blijlevens; Ron A A Mathôt; Waander L van Heerde; Saskia E M Schols
Journal:  J Thromb Haemost       Date:  2020-10-21       Impact factor: 16.036

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.